NCT03819413 - Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

July 15, 2020

Study Completion Date

August 30, 2020

Conditions

Neuromyelitis Optica Spectrum Disorder

Interventions

DIAGNOSTIC_TEST

serum aquaporin 4 antibody (AQP-4-Ab)

All patients suspected to have NMOSD according to the recent diagnostic criteria will be examined for serum aquaporin 4 antibody (AQP-4-Ab) and serum myelin oligodendrocyte glycoprotein antibody (anti-MOG)

DIAGNOSTIC_TEST

serum MOG antibody (anti-MOG)

All patients suspected to have NMOSD according to the recent diagnostic criteria will be examined for serum myelin oligodendrocyte glycoprotein antibody (anti-MOG) if they tested negative for serum aquaporin 4 antibody (AQP-4-Ab)

DIAGNOSTIC_TEST

MRI brain, spine and orbit

All patients suspected to have NMOSD according to the recent diagnostic criteria will have MRI brain, spine and orbit with Gadolinium

Trial Locations (1)

71511

Assiut University Hospital, Asyut

All Listed Sponsors

lead

Assiut University

OTHER